Gene Mutations and Transcriptional Signatures Correlate With Response to Therapy in Advanced Renal Cell Carcinoma
A comprehensive analysis of advanced kidney cancer tumors from the IMmotion151 trial provided new insights on the tumor features that underpin responses to therapy.